A new in vitro approach for investigating the MPTP effect on DA uptake
- 28 November 2000
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 38 (3) , 243-248
- https://doi.org/10.1016/s0197-0186(00)00083-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in manJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- Protection and Potentiation of 1‐Methyl‐4‐Phenylpyridinium‐Induced Toxicity by Cytochrome P450 Inhibitors and Inducer May Be Due to the Altered Uptake of the ToxinJournal of Neurochemistry, 1995
- MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymesFree Radical Biology & Medicine, 1993
- Correlation between (3H) dopamine specific uptake and (3H) GBR 12783 specific binding during the maturation of rat striatumLife Sciences, 1989
- Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+Biochemical and Biophysical Research Communications, 1986
- Neurochemical and Histochemical Characterization of Neurotoxic Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine on Brain Catecholamine Neurones in the MouseJournal of Neurochemistry, 1985
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966